Evidence check: Pharmakogenetik Medicheck in the context of fertility

The provided context lacks direct evidence on pharmacogenetics in fertility. Pharmacogenetic tests like Medicheck can theoretically inform drug metabolism relevant to fertility treatments (e.g., clomiphene, letrozole, gonadotropins). However, clinical evidence for routine use in fertility optimization is limited. Most studies are mechanistic or associative, not from randomized controlled trials. Variants in CYP2D6, CYP3A4, and others show weak or inconsistent associations with treatment outcomes. No specific guidelines recommend preemptive pharmacogenetic testing for fertility. Therefore, the evidence level is 'unclear' – no direct context sources exist, and the broader literature is mixed. Consumers should not rely on such tests alone; results must be interpreted by a specialist. Safety note: do not change medication based solely on genetic results.